The synthesis of 4-substituted l-(arylacetyl)-2-[(alkylamino) methyllpiperazines (10-22, 26, 27, and 30-33) and their activities as K-opioid receptor agonists are described. This includes a range of 4-acyl and 4-carboalkoxy derivatives with the latter series showing the greatest K- agonist activity.
